We found that (1) addition of HSVGM-CSF to human PBMCs activated perforin and granzyme-mediated NK killing of melanoma targets, (2) HSVGM-CSF induced maturation of iDCs, and (3) HSVGM-CSF infection supported the generation of melanoma-specific CTLs. The gene discussed is CSF2; the disease is melanoma.